Loading candles…
IOL Chemicals & Pharmaceuticals Ltd operates in the pharmaceuticals and specialty chemicals industries, producing active pharmaceutical ingredients (APIs) and specialty chemicals for both domestic and export markets. The company is notably the largest global producer of Ibuprofen, holding a 35% share of the world market, and is distinguished as the only company worldwide with complete backward integration for the Ibuprofen API. Its product range includes Ibuprofen as well as chemical products used in the food processing, textiles, and paints industries. Serving the domestic Indian market as well as global export markets, IOL Chemicals & Pharmaceuticals Ltd plays a significant role in its sectors. No information on incorporation year, founders, key management personnel, subsidiaries, or stock exchange listings is provided.
| Details |
|---|
| Date |
|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 20 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and to consider declaration of Interim Dividend for FY 2025-26 | 11 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 7 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 16 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.